Best Options Strategy for GILD
Looking for the best options strategy for Gilead Sciences (GILD)? There is no single answer — the right play depends on your outlook, your risk tolerance and current implied volatility. Below, our free engine shows the highest-scoring defined-risk strategy on the live GILD option chain right now, and a simple map from your view on GILD to the strategy that fits it. Model any of them in the calculator before you trade.
About GILD
Gilead Sciences (GILD) is a major company in biopharma (HIV and oncology). Options traders on GILD tend to watch the HIV franchise, the oncology pipeline and earnings, since these can drive large moves in the share price.
GILD for options traders
Gilead Sciences is a biopharma name with a distinctly low implied volatility profile by sector standards. Its mature HIV franchise generates steady, predictable cash flows that dampen the wild IV swings seen in earlier-stage biotechs. That said, IV does rise meaningfully into earnings and can spike sharply on clinical trial readouts, FDA actions, or surprise pipeline news — events that are harder to calendar and can catch complacent traders off guard.
Because baseline IV is relatively compressed, options buyers get cheaper premium but must be selective about catalysts. Covered calls are a staple strategy for long shareholders looking to generate income on a slower-moving stock. Cash-secured puts appeal to traders comfortable initiating a position at a lower strike. When a binary event approaches — a key trial result or regulatory decision — straddles or long calls become relevant for those expecting an outsized move in either direction.
Today's top-scoring strategy for GILD
Our engine ranks defined-risk strategies on the live GILD chain by probability of profit and risk/reward, then surfaces the best-scoring one. It is an educational illustration, not advice.
| Action | Qty | Type | Strike | Premium |
|---|---|---|---|---|
| Buy | 1× | PUT | $125 | $0.32 |
| Sell | 1× | PUT | $145 | $4.53 |
| Sell | 1× | CALL | $145 | $4.92 |
| Buy | 1× | CALL | $165 | $0.31 |
Simulation
Forward simulation of 6,000 lognormal price paths to expiration — not a historical backtest.
Strategy analysis
Greeks vs price
Price × volatility (today)
| −30% | −15% | IV | +15% | +30% | |
|---|---|---|---|---|---|
| $182 | −$1,101 | −$1,076 | −$1,042 | −$1,003 | −$963 |
| $175 | −$1,040 | −$988 | −$933 | −$883 | −$839 |
| $168 | −$859 | −$791 | −$736 | −$695 | −$667 |
| $160 | −$498 | −$468 | −$455 | −$456 | −$466 |
| $153 | −$44 | −$106 | −$170 | −$231 | −$290 |
| $146 | $218 | $91 | −$23 | −$122 | −$209 |
| $139 | $48 | −$40 | −$125 | −$204 | −$274 |
| $131 | −$440 | −$433 | −$438 | −$453 | −$474 |
| $124 | −$884 | −$830 | −$785 | −$751 | −$728 |
| $117 | −$1,079 | −$1,047 | −$1,010 | −$973 | −$938 |
| $109 | −$1,116 | −$1,109 | −$1,097 | −$1,080 | −$1,059 |
Live scan from 2026-09-14 · quotes delayed ~15 minutes
Historical backtest: how a Iron Butterfly on GILD would have performed
We approximated a Iron Butterfly on GILD, entered repeatedly over the past year (92 historical entries, each held to expiration) with Black-Scholes-modelled entry premiums. Here is how that would have played out on real GILD price history — an educational backtest, not a prediction of future returns.
Approximate: entry premiums are modelled with Black-Scholes from trailing realised volatility, held to expiration and settled against the real historical close. Real fills, implied volatility and slippage differ — treat it as directional context, not exact returns.
Implied volatility
GILD is currently trading with moderate implied volatility, broadly in line with other large-cap stocks. On the options we scanned that was around 28% implied volatility, and higher implied volatility means richer premiums and wider expected moves.
Options on GILD currently price in about 28% implied volatility, versus roughly 26% the stock has actually realised over the past month. The two are roughly in line, so neither buying nor selling premium has a clear volatility edge here.
GILD's IV Rank is 8/100: implied volatility sits 8% of the way between its 18-day low (27%) and high (43%), and is above 53% of recorded days. Premium is historically cheap, which favours net-debit strategies like long options and debit spreads.
Off that volatility, the options market is pricing a move of about ±$11.98 (±8%) in GILD by 2026-10-16 — a range of roughly $134 to $158. Strikes inside that band hold most of the premium and see most of the action.
Across strikes, downside puts on GILD trade at a higher implied volatility than upside calls — the market is paying up for crash protection. That skew favours selling put spreads or buying calls over symmetric trades.
GILD options chain highlights: open interest, volume and skew
The live GILD options chain shows a put/call open-interest ratio of 0.65 (bullish-leaning (more calls)), with at-the-money implied volatility near 28%. Open interest clusters at the $155 call — a common resistance "wall" — and the $135 put, a support "wall": the strikes option writers are most exposed to into expiration.
Snapshot of open interest, volume and implied volatility for the nearest scanned expiration — context, not a trading signal.
GILD insider trading activity (SEC Form 4)
Open-market insider transactions at GILD over roughly the last six months, from SEC Form 4 filings. Open-market buys are the rarer, more telling signal — routine selling under pre-arranged plans is common, so read a net-selling figure with that in mind.
| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| WELTERS ANTHONY | Sell | 6,880 | $1.0M | 2026-08-26 |
| WELTERS ANTHONY | Sell | 3,402 | $504K | 2026-08-26 |
| WELTERS ANTHONY | Sell | 4,600 | $685K | 2026-08-26 |
| WELTERS ANTHONY | Sell | 3,118 | $462K | 2026-08-26 |
| O'Day Daniel Patrick | Sell | 600 | $79K | 2026-08-03 |
| O'Day Daniel Patrick | Sell | 7,700 | $1.0M | 2026-08-03 |
Source: SEC Form 4 filings via Finnhub. Open-market purchases (P) and sales (S) only — grants, option exercises, gifts and tax withholding are excluded. Informational context, not investment advice.
GILD congressional trading (STOCK Act)
Recent GILD stock trades disclosed by members of the US Congress under the STOCK Act. Lawmakers must report trades within 45 days; amounts are disclosed only as broad ranges, and a trade is not an endorsement — treat it as context, not a signal.
| Member | Chamber | Action | Amount | Date |
|---|---|---|---|---|
| Ro Khanna (CA17) | House | Sell | $1,001 - $15,000 | 2026-08-10 |
| Ro Khanna (CA17) | House | Sell | $1,001 - $15,000 | 2026-07-07 |
Source: US House & Senate financial disclosures via Financial Modeling Prep. Amounts are the disclosed ranges. Informational context, not investment advice.
Liquidity and tradeability
GILD options are reasonably liquid, with bid-ask spreads around 7.3% near the money. Defined-risk spreads and condors are workable; use limit orders and watch the fill on wider multi-leg trades.
Earnings & IV crush
GILD's next earnings report is due around October 29, 2026. Options that expire after it price in a binary move, so their implied volatility is elevated and usually collapses right after the announcement — an "IV crush". If your expiration falls before this date, the trade sidesteps the event.
Dividend and assignment risk
GILD pays a dividend of about 2.3% a year, so short or covered calls on it carry early-assignment risk around each ex-dividend date — in-the-money calls are most exposed just before the stock goes ex-dividend.
Key figures
- Market cap
- $181.5B
- Beta (vs market)
- 0.35
- 52-week range
- $108.46–$157.29 (76% up the range)
- Short interest
- 1.9% of float · 3.6 days to cover
Other strong setups for GILD
If your view on GILD differs, these also scored well in the latest scan:
How to choose an options strategy for GILD
Start with your outlook on GILD, then match it to a defined-risk structure. Here are the most common choices and when each makes sense:
Bullish
Buy a call for leverage with capped risk, or a bull call spread to lower the cost and breakeven when you have a target price.
Long Call → Bull Call Spread →Bearish
Buy a put to profit from a decline with defined risk, or a bear put spread to cheapen the trade when you expect a measured move down.
Long Put → Bear Put Spread →Neutral
Sell an iron condor to collect premium while GILD stays between two strikes, or write a covered call against shares you already own.
Iron Condor → Covered Call →⧉ Embed this free calculator on your site →
How we pick the best strategy
For each ticker we pull the live option chain, build every supported strategy around the at-the-money strikes, and score them on probability of profit, risk/reward and capital efficiency — favouring defined-risk structures where the maximum loss is known up front. Methodology →
Open GILD in the free calculator →
Frequently asked questions
What is the best options strategy for GILD?
It depends on your outlook. Bullish traders often use a long call or bull call spread on GILD; bearish traders a long put or bear put spread; neutral traders an iron condor or covered call. Our live scan above shows the current highest-scoring defined-risk play.
Are GILD options liquid enough to trade?
Gilead Sciences (GILD) is among the most actively-traded US options, which usually means tight bid/ask spreads and plenty of strikes and expirations — though you should always check the open interest and spread on the exact contract.
How much money do I need to trade GILD options?
Buying a single GILD call or put can cost as little as the premium (often one to a few hundred dollars), while income strategies like a cash-secured put need enough capital to buy 100 shares if assigned.
Is this financial advice?
No. Everything here is educational and uses delayed, third-party data. It is not a recommendation to trade GILD or any security. Do your own research.
What does Gilead Sciences do?
Gilead Sciences (GILD) operates in the Drug Manufacturers - General industry. The "About Gilead Sciences" section above gives a fuller picture of what the company does and how it earns money.
Does Gilead Sciences pay a dividend?
Yes — Gilead Sciences currently pays a dividend yielding about 2.3%. If you hold the shares (for example to write a covered call), the ex-dividend date can trigger early assignment, so check it beforehand.
When does Gilead Sciences next report earnings?
Gilead Sciences's next earnings are expected around October 29, 2026. Implied volatility usually climbs into the report and drops sharply afterwards (IV crush) — important for any options position held over the date.
Price trend
Tickers related to GILD
Comparing GILD with similar names can help you choose the best options strategy:
Company information
- Headquarters
- 333 Lakeside Drive, Foster City, CA, 94404, United States
- Industry
- Drug Manufacturers - General
- Employees
- 17,000
- CEO
- Mr. Daniel Patrick O'Day
- Phone
- 650 574 3000
- Website
- www.gilead.com
- Investor relations
- investors.gilead.com/phoenix.zhtml?c=69964&p=irol-irhome
Best Options Strategy by Ticker →
Educational use only. Quotes are delayed ~15 minutes and nothing here is financial advice. Options trading involves substantial risk of loss. Privacy · Terms.